Search Results - "Weg, E.S."

Gastrointestinal Toxicity Following Proton and Photon Radiation for Prostate Cancer in Patients with Inflammatory Bowel Disease by Wairiri, L.W., Liao, J.J., Chen, J., Weg, E.S.

“…Inflammatory bowel disease (IBD) has been considered a relative contraindication for radiation for prostate cancer (PC) due to concern for gastrointestinal…”
Get full text

Genomic Assessment of a High Grade Low PSA Prostate Cancer Cohort by Weg, E.S., Setton, J., McBride, S.

Get full text

Clinicopathologic Features of Prostate Cancer with Mesorectal Lymph Node Involvement on PSMA or Fluciclovine PET/CT by Barbour, A.B., Gutschenritter, T., Chen, D.L., Gulhane, A., Iravani, A., Chen, J., Liao, J.J., Weg, E.S.

“…Advanced PET imaging has shown more prevalent mesorectal lymph node (LN) involvement in prostate cancer than previously appreciated. The clinical features…”
Get full text

Proton Radiation Therapy for Stage IIA/IIB Testicular Seminoma by Lui, A., Zeng, J., Chen, J., Weg, E.S., Ellis, W., Psutka, S.P., Nyame, Y.A., Yezefski, T., Lin, D., Schade, G., Liao, J.J.

“…Testicular seminoma affects young men and is associated with very favorable prognosis. The evolution in treatment paradigm has focused on minimizing acute and…”
Get full text

Dose-Escalated Intensity Modulated Radiation Therapy for Prostate Cancer: 15-Year Outcomes Data by Weg, E.S., Kollmeier, M.A., McBride, S., Pei, X., Zelefsky, M.J.

Get full text

Abiraterone, Androgen Deprivation Therapy, and Radiotherapy for Localized Intermediate/High Risk Prostate Cancer: Long-Term Follow-Up of the RAD1 Phase 2 Trial by Liao, J.J., Mostaghel, E., Russell, K.J., Dalkin, B., Ellis, W., Lin, D., Wright, J., Schade, G., Nyame, Y.A., Yu, E.Y., Nelson, P., Grivas, P., Schweizer, M., Cheng, H.H., Yezefski, T., Hawley, J.E., Chen, J., Weg, E.S., Nguyen, M.H., Montgomery, B.

Get full text

Assessing the Risk of Pathologic Lymph Node Involvement in Intermediate Risk Prostate Cancer by Weg, E.S., Holt, S.K., Elia, M., Schade, G., Wright, J., Ellis, W., Lin, D., True, L., Chen, J., Zeng, J., Liao, J.J., Nyame, Y.A.

“…Most intermediate risk (IR) prostate cancer (PCa) patients are predicted to have low rates of pelvic lymph node (PLN) involvement. The standard of care for…”
Get full text

Assessing Outcomes in the Management of Postmastectomy Local-Regional Recurrences in Breast Cancer by Weg, E.S., Pei, X., Cahlon, O., Morrow, M., Powell, S.N., McCormick, B.

Get full text

Improved Survival and Intracranial Control Associated With Radiation Necrosis After Ipilimumab and Stereotactic Radiosurgery for Melanoma Brain Metastases by Wild, A., Kiess, A.P., Yang, T.J., Weg, E.S., Kohutek, Z.A., Wolchok, J.D., Postow, M.A., Tabar, V.S., Brennan, C.W., Chan, T.A., Yamada, Y., Beal, K.

Get full text